COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 11.440
AS - Asia 4.889
EU - Europa 3.782
SA - Sud America 921
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 21.137
Nazione #
US - Stati Uniti d'America 11.312
SG - Singapore 2.555
UA - Ucraina 1.118
CN - Cina 1.018
IT - Italia 824
BR - Brasile 776
HK - Hong Kong 572
DE - Germania 547
FI - Finlandia 381
RU - Federazione Russa 280
VN - Vietnam 240
IE - Irlanda 196
TR - Turchia 138
SE - Svezia 125
GB - Regno Unito 100
IN - India 79
CA - Canada 78
KR - Corea 70
AR - Argentina 67
FR - Francia 54
BD - Bangladesh 42
MX - Messico 33
IQ - Iraq 28
JP - Giappone 26
PL - Polonia 24
ZA - Sudafrica 24
AT - Austria 23
BE - Belgio 23
NL - Olanda 22
EU - Europa 19
EC - Ecuador 18
ID - Indonesia 17
IR - Iran 17
CO - Colombia 15
CZ - Repubblica Ceca 14
PK - Pakistan 13
ES - Italia 12
UZ - Uzbekistan 12
MA - Marocco 11
VE - Venezuela 11
CL - Cile 10
EG - Egitto 10
PE - Perù 10
JO - Giordania 8
KE - Kenya 7
LB - Libano 7
DZ - Algeria 6
PY - Paraguay 6
AZ - Azerbaigian 5
CH - Svizzera 5
SA - Arabia Saudita 5
TN - Tunisia 5
UY - Uruguay 5
EE - Estonia 4
IL - Israele 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
LT - Lituania 3
PS - Palestinian Territory 3
RO - Romania 3
TG - Togo 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BO - Bolivia 2
BT - Bhutan 2
BW - Botswana 2
CM - Camerun 2
ET - Etiopia 2
LK - Sri Lanka 2
LV - Lettonia 2
ME - Montenegro 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
Totale 21.119
Città #
Woodbridge 1.428
Fairfield 1.110
Singapore 942
Ann Arbor 912
Jacksonville 796
Ashburn 788
Chandler 594
Houston 578
Hong Kong 572
Beijing 526
Dearborn 501
Wilmington 495
Seattle 456
Cambridge 370
Boardman 282
Princeton 217
Dublin 194
Udine 150
Los Angeles 147
Izmir 107
Buffalo 100
Dallas 96
Hefei 91
San Diego 83
Ho Chi Minh City 66
Seoul 60
Redondo Beach 59
São Paulo 57
Hanoi 55
Munich 49
Des Moines 48
New York 48
Ogden 48
Dong Ket 47
Norwalk 44
Milan 42
Redmond 42
Ottawa 40
Nanjing 37
Rome 33
San Mateo 32
Mumbai 31
Kunming 30
Nuremberg 27
Guangzhou 25
Helsinki 25
Rio de Janeiro 25
Santa Clara 24
Tokyo 24
Brussels 23
Warsaw 22
Belo Horizonte 20
Phoenix 20
Brooklyn 19
The Dalles 19
Trieste 19
Johannesburg 18
Stockholm 17
Frankfurt am Main 16
London 16
San Francisco 16
Shanghai 16
Ankara 14
Atlanta 14
Vienna 14
Baghdad 13
Chennai 13
Chicago 13
Denver 13
Goiânia 13
Mcallen 13
Orem 13
Boston 12
Brno 12
Council Bluffs 12
Grafing 12
Montreal 12
Porto Alegre 12
Falls Church 11
Jinan 11
Poplar 11
Turku 11
Washington 11
Bologna 10
Brasília 10
Fortaleza 10
Amsterdam 9
Dhaka 9
Düsseldorf 9
Fuzhou 9
Mexico City 9
Pignone 9
Salvador 9
Tashkent 9
Toronto 9
Turin 9
Vicenza 9
Zhengzhou 9
Curitiba 8
Espoo 8
Totale 13.208
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 258
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 217
Aldosterone and the heart: from basic research to clinical evidence 187
Aldosterone and Left Ventricular Remodeling 179
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 175
Aldosterone, Organ Damage, and Dietary Salt 166
Aldosterone and the heart: still an unresolved issue? 165
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 160
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 158
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 156
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 155
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 154
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 149
The emergent cardiovascular risk factors and organ damage in arterial hypertension 149
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 149
Diabetes, diabetic complications, and blood pressure targets 147
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 147
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 147
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 144
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 143
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 143
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 143
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 141
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 140
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 140
Treatment of primary aldosteronism and organ protection 140
Benzodiazepines: an old class of new antihypertensive drugs? 139
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 138
Salt, hypertension, and cardiovascular disease 137
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 137
Renal function in primary aldosteronism 135
Cardiovascular outcomes in patients with primary aldosteronism after treatment 135
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 135
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 134
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 133
Kidney in primary aldosteronism: a key determinant of treatment outcome 132
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 131
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 130
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 130
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 129
Potassium-sparing diuretics in hypertension 127
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 126
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 126
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 125
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 125
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 125
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 124
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 124
Hypertension and type 2 diabetes: lights and shadows about causality 120
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 118
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 118
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 118
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 117
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 117
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 117
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 117
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 116
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 116
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 116
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 115
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 115
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 115
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 114
Uricaemia and left ventricular mass in hypertensive patients 114
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 114
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 114
Renal function in primary aldosteronism: revisiting the concept of “renin escape” 114
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 113
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 113
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 111
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 111
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 110
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 110
Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new 107
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY 106
Endothelial function in patients with non-alcoholic fatty liver disease 106
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 105
Reversal of left ventricular hypertrophy after treatment is related to severity of disease in patients with primary aldosteronism 105
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 105
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 104
Cardiac and renal damage in primary aldosteronism 103
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 103
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 103
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 102
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 102
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 102
Hyperaldosteronism and Left Ventricular Hypertrophy 102
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 102
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 100
. L’attività fisica migliora la sensibilità all’insulina ed i fattori di rischio protrombotico in una popolazione di pazienti ipertesi 99
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 99
Long-term out come of renal cysts in patients with primary aldosteronism 98
Ipertensione arteriosa e poliglobulia in paziente con stenosi multiple delle arterie renali 97
Effects of renal revascularization on renal and cardiac function in hypertensive patients 97
Renal and cardiovascular outcomes in renal revascularization in patients with resistant hypertension. 97
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 97
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 97
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 97
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 97
Long-term outcome of renal cysts in primary aldosteronism 95
Totale 12.629
Categoria #
all - tutte 87.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.667 0 0 0 0 0 333 136 278 411 81 292 136
2021/20221.596 76 182 64 125 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024520 91 32 41 9 82 58 23 12 70 20 8 74
2024/20253.580 80 265 141 116 72 155 173 186 415 294 638 1.045
2025/20263.928 476 714 543 601 1.065 529 0 0 0 0 0 0
Totale 21.723